Abstract:Background:Bone marrow-derived mesenchymal stem cells (MSCs) have been proved in vitro to inducible differentiate into many kinds of cells of mesenchymal tissues such as osteocytes,chondrocytes, adipocytes,myocytes et al,especially myocardium cells. Recently it was shown that the wall thickness and heart function were improved after MSCs implantation in animal experiments and large-scale clinical trials. But other studies didn’t show that grafted stem cells can bring benefits to heart function in patients with cardiac disease. These therapeutic differences may be rise at least because of lack of visible method to trace in vivo grafted stem cells bio-behaviors such as survive,proliferation,distribution and differentiation. In recent decade an in vivo cellular tracking techniques by using luciferase marker so called BLU have been developed for long-term study of stem cells homing and migration. Bioluminescent imaging ( BLU) technology is a technology to integrate exogenous report luciferase genes into host cells,and express luciferase. This enzyme will give out the visible light when it reacts with its substrate fluorescein under the condition of existing O2 and ATP,to track living cells in real time. In BLU technology the vector for gene transfection is considered a principal because it very closely links to gene transfection efficiency and hence cells lumination. Objective:By using reconstructed-lentivirus vector transfection and bioluminescent imaging techniques to monitor in vivo survival and proliferation and migration of grafted human mesenchymal stem cells (hMSCs) in mice. Methods:Firefly-Luciferase (LUC) -Lentivirus vector were constructed and co-cultured with hMSCs in vitro. Then transfected hMSCs were subcutaneously injected into mice. Either in vitro and in vivo biophotonic imaging of hMSCs were detected by using Xenogen Visible System. Results:1. When multiplicity of infection (MOI) was 100,transfection efficiency of LUC-lentivirus vector could come to (29. 6 ±1. 5)%. Transfected- hMSCs had expressed LUC after 20 successive generation. Indicating this reconstructed lentivirus-LUC-vector has the characteristics of high transfection sensitivity to hMSCs,and high stability for exogenous reporter gene integration and its expression. 2. No morphological and proliferation effect on hMSCs were observed after co- culture with constructed lentivirus vector for 20 generation. This demonstrating that neither lentivirus vector nor exogenous reporter gene has cytotoxicity to targeting cells. 3. Detected in vivo bioluminescence intensity was positively correlated with grafted mass of transfected-LUC hMSCs ( R2 = 0. 9826 ). 4. Since cellular transplantation,in vivo bioluminescence signal bounded injection location were detectable and the signal intensity were linear faded out until to 6th day. Means the survival,homing,proliferation and migration of Firefly-Luciferase gene transfected hMSCs can be quantitatively in vivo monitored in real time. Conclusion: Reconstructed descytotoxicityly lentivirus vector is an effective and safety tool for Firefly-Luciferase gene integrating into hMSCs. Thus by using bioluminescent tracer techniques the phenotype and potential involving homing,proliferation and migration of LUC-transfectied hMSCs can be quantitatively in vivo real-timely monitored.

Molecular Imaging for Comparison of Different Growth Factors on Bone Marrow-Derived Mesenchymal Stromal Cells’ Survival and ProliferationIn Vivo

Migration and localization of bone marrow mesenchymal stem cells labeled by DAPI in the brain of glioma rat models

In Vivo Tracking of Systemically Administered Allogeneic Bone Marrow Mesenchymal Stem Cells in Normal Rats through Bioluminescence Imaging

Abstract 248: Comparison Of Transplantation Of Bone Marrow-derived Stem Cells, Adipose-derived Stem Cells And Endometrium- Derived Stem Cells In The Infarcted Heart

In Vitro Expansion Affects the Response of Human Bone Marrow Stromal Cells to Irradiation

[Effects of IGF-I and BMP-2 Combined Application on Promoting Proliferation, Differentiation and Calcification of MC 3T3-E1 and NIH 3T3 Cells].

Multimodality Imaging in the Assessment of Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy.

Culture and molecular imaging identification of adipose derived mesenchymal stem cells with stable reporter gene expression in vitro and in vivo

Observation of bone marrow-derived mesenchymal stem cells targeting glioma with in vivo bioluminescence imaging

Molecular Imaging to Monitor Repair of Myocardial Infarction Using Genetically Engineered Bone Marrow-Derived Mesenchymal Stem Cells.

In Vivo MRI Tracking of Bone Mesenchymal Stem Cell Viability with a T1-T2 Switchable Contrast Agent

The Influence of Bone Marrow Stem Cells Transfected by VEGF165 on the Survival Rate of Transplanted Fat Tissue

Gliko BMSC: A potential strategy of treatment for renal fibrosis

In Vitro Effects of Low-Level Laser Irradiation for Bone Marrow Mesenchymal Stem Cells: Proliferation, Growth Factors Secretion and Myogenic Differentiation

IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway

In Vivo Monitoring of Hmscs Stem Cell by Bioluminescent Tracer in Mice

Effect of the PI3K/AKT signaling pathway on hypoxia-induced proliferation and differentiation of bone marrow-derived mesenchymal stem cells

Evaluation of the Ghrelin protective effect on bone marrow mesenchymal stem cells with hypoxia injury by imaging

Effects of Transfection of Integrin-Linked Kinase Gene to Bone Mesenchymal Stem Cells on the Paracrine Action in Rats

Multichannel-optical imaging for in vivo evaluating the safety and therapeutic efficacy of stem cells in tumor model in terms of cell tropism, proliferation and NF-κB activity

Culture, Identification of Mice Bone Marrow Mesenchymal Stem Cells and the Expression of Survivin